Visualization, quantification and correlation of brain atrophy with clinical symptoms in spinocerebellar ataxia types 1, 3 and 6

BACKGROUND AND OBJECTIVE Biomarkers to monitor neurological dysfunction in autosomal dominant inherited spinocerebellar ataxias (SCA) are lacking. We therefore aimed to visualize, quantify and correlate localized brain atrophy with clinical symptoms in SCA1, SCA3, and SCA6. METHODS We compared patients suffering from SCA1 (n=48), SCA3 (n=24), and SCA6 (n=10) with 32 controls using magnetic resonance imaging (MRI) on four different scanners in eight centers followed by voxel-based morphometry (VBM) and quantitative three-dimensional (3D) volumetry. RESULTS SCA1 and SCA3 patients presented with severe atrophy in total brainstem (consisting of midbrain, pons, and medulla), pons, medulla, total cerebellum, cerebellar hemispheres and cerebellar vermis, putamen and caudate nucleus. Atrophy in the cerebellar hemispheres was less severe in SCA3 than in SCA1 and SCA6. Atrophy in SCA6 was restricted to the grey matter of the cerebellum (VBM and volumetry), total brainstem and pons (volumetry only). Overall, we did not observe substantial atrophy in the cerebral cortex. A discriminant analysis taking into account data from pons, cerebellar hemispheres, medulla, midbrain and putamen achieved a reclassification probability of 81.7% for SCA1, SCA3, and SCA6. The repeat length of the expanded allele showed a weak negative correlation with the volume of the brainstem, pons, caudate nucleus and putamen in SCA3, and a weak correlation with the pons in SCA1, whereas no such correlation was found in SCA6. Clinical dysfunction as measured by the Scale for the Assessment and Rating of Ataxia (SARA) and the Unified Huntington's Disease Rating Scale functional assessment correlated best with the atrophy of pons in SCA1, with total brainstem atrophy in SCA3 and atrophy of total cerebellum in SCA6. CONCLUSIONS Our data provide strong evidence that MRI is an attractive surrogate marker for clinical studies of SCA. In each SCA genotype clinical dysfunction may be caused by different patho-anatomical processes.

[1]  N Makris,et al.  Striatal volume loss in HD as measured by MRI and the influence of CAG repeat , 2001, Neurology.

[2]  Johannes Dichgans,et al.  Magnetic resonance imaging-based volumetry differentiates progressive supranuclear palsy from corticobasal degeneration , 2004, NeuroImage.

[3]  M Skalej,et al.  Autosomal dominant cerebellar ataxia type I. MRI-based volumetry of posterior fossa structures and basal ganglia in spinocerebellar ataxia types 1, 2 and 3. , 1998, Brain : a journal of neurology.

[4]  Thorsten Schmidt,et al.  Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis , 2004, The Lancet Neurology.

[5]  Martin Skalej,et al.  Visualization and quantification of disease progression in multiple system atrophy , 2006, Movement disorders : official journal of the Movement Disorder Society.

[6]  F. Jessen,et al.  Multicenter assessment of reliability of cranial MRI , 2006, Neurobiology of Aging.

[7]  Franco Taroni,et al.  Spinocerebellar ataxia type 1. , 2012, Handbook of clinical neurology.

[8]  Xiao-Li Meng,et al.  Comparing correlated correlation coefficients , 1992 .

[9]  T Klockgether,et al.  The natural history of degenerative ataxia: a retrospective study in 466 patients. , 1998, Brain : a journal of neurology.

[10]  Francesco Fera,et al.  Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclear palsy. , 2006, Brain : a journal of neurology.

[11]  U Klose,et al.  Reliability and exactness of MRI‐based volumetry: A phantom study , 1996, Journal of magnetic resonance imaging : JMRI.

[12]  Michael Schocke,et al.  Atrophy pattern in SCA2 determined by voxel-based morphometry , 2003, Neuroreport.

[13]  Jacob Cohen.  Statistical Power Analysis for the Behavioral Sciences , 1969, The SAGE Encyclopedia of Research Design.

[14]  M. Skalej,et al.  A new semiautomated, three‐dimensional technique allowing precise quantification of total and regional cerebellar volume using MRI , 1998, Magnetic resonance in medicine.

[15]  P. Maruff,et al.  An optimized method for estimating intracranial volume from magnetic resonance images , 2000, Magnetic resonance in medicine.

[16]  T Yuasa,et al.  Progressive atrophy of cerebellum and brainstem as a function of age and the size of the expanded CAG repeats in the MJD1 gene in Machado‐Joseph disease , 1998, Annals of neurology.

[17]  I. Shoulson,et al.  A prospective evaluation of cognitive decline in early Huntington's disease , 1995, Neurology.

[18]  Andreas R. Luft,et al.  Magnetic resonance imaging in spinocerebellar ataxias , 2008, The Cerebellum.

[19]  Anders M. Dale,et al.  Reliability of MRI-derived measurements of human cerebral cortical thickness: The effects of field strength, scanner upgrade and manufacturer , 2006, NeuroImage.

[20]  P. Lachenbruch.  Statistical Power Analysis for the Behavioral Sciences (2nd ed.) , 1989 .

[21]  Graeme D. Jackson,et al.  Multi-site voxel-based morphometry: Methods and a feasibility demonstration with childhood absence epilepsy , 2008, NeuroImage.

[22]  Jane S. Paulsen,et al.  Unified Huntington's disease rating scale: Reliability and consistency , 1996, Movement disorders : official journal of the Movement Disorder Society.

[23]  Nick C Fox,et al.  Imaging cerebral atrophy: normal ageing to Alzheimer's disease , 2004, The Lancet.

[25]  David Araújo,et al.  Correlation between voxel based morphometry and manual volumetry in magnetic resonance images of the human brain. , 2008, Anais da Academia Brasileira de Ciencias.

[26]  M. Skalej,et al.  Magnetic resonance imaging–based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy , 1999, Annals of neurology.

[27]  G Belli,et al.  Brainstem neurodegeneration correlates with clinical dysfunction in SCA1 but not in SCA2. A quantitative volumetric, diffusion and proton spectroscopy MR study. , 2004, Brain : a journal of neurology.

[28]  Paola Giunti,et al.  Reliability and validity of the International Cooperative Ataxia Rating Scale: A study in 156 spinocerebellar ataxia patients , 2006, Movement disorders : official journal of the Movement Disorder Society.

[29]  Nick C Fox,et al.  Imaging of onset and progression of Alzheimer's disease with voxel-compression mapping of serial magnetic resonance images , 2001, The Lancet.

[30]  L. Baliko,et al.  Spinocerebellar Ataxia Types 1, 2, 3 and 6: the Clinical Spectrum of Ataxia and Morphometric Brainstem and Cerebellar Findings , 2008, The Cerebellum.

[31]  A W Toga,et al.  Pontine and cerebellar atrophy correlate with clinical disability in SCA2 , 2006, Neurology.

[32]  Karsten Specht,et al.  Voxel-based analysis of multiple-system atrophy of cerebellar type: complementary results by combining voxel-based morphometry and voxel-based relaxometry , 2005, NeuroImage.

[33]  Elsdon Storey,et al.  Spinocerebellar ataxia type 15 , 2008, The Cerebellum.

[34]  Carsten Lukas,et al.  Dissociation of grey and white matter reduction in spinocerebellar ataxia type 3 and 6: A voxel-based morphometry study , 2006, Neuroscience Letters.

[35]  Nick C Fox,et al.  Normalization of cerebral volumes by use of intracranial volume: implications for longitudinal quantitative MR imaging. , 2001, AJNR. American journal of neuroradiology.

[36]  J Kassubek,et al.  Topography of cerebral atrophy in early Huntington’s disease: a voxel based morphometric MRI study , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[37]  Christian Kremser,et al.  Trace of diffusion tensor differentiates the Parkinson variant of multiple system atrophy and Parkinson's disease , 2004, NeuroImage.

[38]  A. Ginestroni,et al.  Brain structural damage in spinocerebellar ataxia type 1 , 2008, Journal of Neurology.

[39]  L. Baliko,et al.  Scale for the assessment and rating of ataxia , 2006, Neurology.

[40]  Mario Mascalchi,et al.  Brain white matter damage in SCA1 and SCA2. An in vivo study using voxel-based morphometry, histogram analysis of mean diffusivity and tract-based spatial statistics , 2008, NeuroImage.

[41]  Jane S. Paulsen,et al.  Unified Huntington's disease rating scale: Reliability and consistency , 1996, Movement disorders : official journal of the Movement Disorder Society.